Real World, Pharmacy-assessed Adherence to New Onset Entresto® (Sacubitril/Valsartan) in Patients With Chronic Heart Failure
Clinical trial NCT05870709 · WITHDRAWN
Trial details
- NCT number
- NCT05870709
- Sponsor
- Novartis Pharmaceuticals
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-15
- Primary completion
- 2024-10-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.